Spark Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ONCE and buy or sell other stocks, ETFs, and their options commission-free!About ONCE
Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating diseases. The founding team includes scientists who have led the advancement of gene therapy over the past two decades, establishing human proof of concept of the expression of gene therapy in the eye and liver.
CEOSylke Poehling, Ph.D
CEOSylke Poehling, Ph.D
Employees—
Employees—
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2013
Founded2013
Employees—
Employees—
ONCE Key Statistics
Market cap4.29B
Market cap4.29B
Price-Earnings ratio-17.35
Price-Earnings ratio-17.35
Dividend yield—
Dividend yield—
Average volume601.86K
Average volume601.86K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$114.20
52 Week high$114.20
52 Week low$34.53
52 Week low$34.53